CytomX Therapeutics, Inc.CTMXNASDAQ
Loading
Asset Growth AcceleratingAccelerating
Percentile Rank75
5Y CAGR+38.3%
Studio
Year-over-Year Change

Year-over-year total asset growth rate

5Y CAGR
+38.3%/yr
Long-term compound
Percentile
P75
Within normal range
vs 5Y Ago
5.1x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202525.75%
2024-40.27%
2023-22.65%
2022-23.13%
2021-5.37%
20205.09%
2019-25.34%
201814.95%
201799.69%
20160.97%